Sichenzia Ross Friedman Ference LLP Acted as Placement Agent Counsel on MabVax Therapeutic’s $11.7M PIPE

New York, NY – April 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that Axiom Capital Management Inc. has completed a private placement of MabVax Therapeutics Holdings, Inc. (OTC: MBVX) Units. MabVax is a clinical-stage biopharmaceutical company focused on developing vaccine and monoclonal anti-body based therapeutics. The private placement consisted of 15,486,001 Units offered at $0.75 per Unit for aggregate proceeds of $11,714,501. Additionally, each Unit consisted of one share of common stock and a 30-month warrant to purchase one-half of one share of common stock where the warrants are exercisable at $1.50 per each whole share of common stock.

The private placement was led by OPKO Health, Inc. (NYSE: OPK) and the Frost Gamma Investments Trust. Sichenzia Ross Friedman Ference LLP Partners Harvey Kesner, Tara Guarneri-Ferrara, Associate Tim O’Brien and Foreign Attorney Ekaterina Williams represented Axiom Capital Management.

To learn more about SRFK, visit www.srf.law, SRFK’s LinkedIn and our Twitter page: @SRFKLLP

Media Contact:

pr@srf.law

(212)-930-9700

• About
• Latest Posts

Sichenzia Ross Ference Carmel LLP

SRFC is a full-service law firm with nationally recognized corporate, securities, and litigation practices that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel 任命 Matilde Tysz 为首席战略官 - April 9, 2025
• Kleidman, Carl - April 8, 2025
• Sichenzia Ross Ference Carmel LLP 代表 ThinkEquity 参与 Perfect Moment Ltd. 的 640 万美元私募。 - April 8, 2025